Balyasny Asset Management LLC Avrobio, Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.68 - $1.11 $9,120 - $14,887	13,412 New	13,412 $9,000
Q4 2020 Feb 16, 2021	SELL	$12.79 - $17.1 $1.59 Million - $2.13 Million	-124,494 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.99 - $19.41 $1.62 Million - $2.42 Million	124,494 New	124,494 $1.62 Million
Q1 2020 May 15, 2020	SELL	$10.08 - $27.21 $599,628 - $1.62 Million	-59,487 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $776,305 - $1.3 Million	59,487 New	59,487 $1.2 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.